Mechanism of Action

A number of theories have been put forward to account for the hypotensive action of a-methyldopa. Current evidence suggests that for a-methyldopa to be an anti-hypertensive agent, it must be converted to a-methyl-norepinephrine; however, its site of action appears to be in the brain rather than in the periphery. Systemically administered a-methyldopa rapidly enters the brain, where it accumulates in noradrenergic nerves, is converted to a-methylnorepinephrine, and is released. Released a-methylnorepinephrine activates CNS a-adrenoceptors whose function is to decrease sympathetic outflow. Why a-methylnorepinephrine decreases sympathetic outflow more effectively than does the naturally occurring transmitter is not entirely clear.

Healthy Weight Loss For Teens

Healthy Weight Loss For Teens

Help your Teen Lose Weight Easily And In A Healthy Way. You Are About to Discover What psychological issues overweight teens are facing and how do you go about parenting an overweight teen without creating more problems?

Get My Free Ebook

Post a comment